Home/Filings/4/0001179110-16-020724
4//SEC Filing

MEDICINES CO /DE 4

Accession 0001179110-16-020724

CIK 0001113481operating

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 6:32 PM ET

Size

10.2 KB

Accession

0001179110-16-020724

Insider Transaction Report

Form 4
Period: 2016-02-29
Frazier Jeff
EVP, Chief Human Strategy Ofcr
Transactions
  • Tax Payment

    Common Stock

    2016-03-02$33.85/sh422$14,28534,000 total
  • Award

    Common Stock

    2016-02-29$27.34/sh+305$8,33927,158 total
  • Award

    Common Stock

    2016-03-01+7,26434,422 total
  • Award

    Stock Option (right-to-buy)

    2016-03-01+47,64447,644 total
    Exercise: $33.04Exp: 2026-03-01Common Stock (47,644 underlying)
Footnotes (4)
  • [F1]Shares of common stock acquired pursuant to The Medicines Company Employee Stock Purchase Plan ('ESPP') for the ESPP purchase period beginning September 1, 2015 and ending February 29, 2016. In accordance with the terms of the ESPP, these shares were purchased based on 85% of the fair market value closing price of the issuer's common stock on February 29, 2016.
  • [F2]Shares of restricted stock vest in 25% increments on each anniversary of the date of grant, until fully vested.
  • [F3]Shares of common stock were withheld for payment of taxes in connection with the vesting of 1,239 shares of restricted stock from previously reported grants.
  • [F4]The option vests in forty-eight equal installments beginning April 1, 2016.

Issuer

MEDICINES CO /DE

CIK 0001113481

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001113481

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:32 PM ET
Size
10.2 KB